|
The criteria for eligible cases in a registry depend upon
the governing agencies of the registry. Along with state-specific
reportable cases, registries participating in the Approvals
Program of the Commission on Cancer (CoC) of the American
College of Surgeons (ACoS)
must use the reportable
list defined by the CoC.
The CoC requires the cancer registry to collect information
on malignancies diagnosed and/or treated at the hospital,
except for in-situ malignancies of the cervix and localized
basal and squamous cell carcinomas of the skin. The cancer
committee is responsible for developing a reportable list
that identifies all types of cases to be included in the cancer
registry database. The reportable list identifies malignancies
with a behavior code (fifth digit) of 2 or 3 as identified
in the International Classification of Diseases for Oncology,
3rd edition (ICD-O-3).
In addition, the reportable list identifies reportable-by-agreement
benign or borderline disease processes not required by the
Commission on Cancer or state registries. These benign or
borderline cases may be institution or registry-specific and
mandated by the institution's cancer committee or governing
board. Eligible basal, squamous, and basosquamous cell cancers
of the skin should be identified. Ultimately, the reportable
list includes malignant cases, reportable-by-agreement and
diagnoses to be entered into the cancer registry database.
A non-reportable case (diagnoses that should not be included)
should also be maintained.
The reportable list should be reviewed annually by the cancer
committee or governing agency to determine the addition or
deletion of reportable cases. When developing or changing
the reportable list, it is important to remember that collecting
additional reportable-by-agreement cases may necessitate additional
staffing due to increased case load and related activities.
|
